Susan G. Komen Central and South Jersey (Komen CSNJ) announced a new investment in its commitment to support local women dealing with a breast cancer diagnosis. As part of the organization’s Bold Goal to reduce current breast cancer deaths by 50 percent in the U.S. by 2026, Komen CSNJ is contributing $25,000 to Komen’s National Treatment Assistance Program, with funds earmarked to provide direct financial assistance for local patients dealing with the crippling costs associated with breast cancer treatment.
After an individual is diagnosed with breast cancer, the goal is for them to receive treatment to combat the disease. Even with insurance coverage, the out-of-pocket cost for initial treatment can be more than $5,000, which is five times more than what the average American has in their savings account (Huddleston). By investing into Komen’s National Treatment Assistance Program, Komen CSNJ is able to provide limited financial assistance, education and support services to low-income, underinsured or uninsured breast cancer patients throughout Central and South Jersey.
To be eligible, patients must have incomes at or below 250% of the federal poverty line and an active breast cancer diagnosis. The program covers limited costs associated with breast cancer treatment such as oral pain medication, anti-nausea medication, oral chemotherapy/hormone therapy, child care/elder care, home care, transportation, lymphedema care and supplies, and durable medical equipment.
For more information, call the Susan G. Komen Breast Care Helpline Monday through Friday, 9AM-10PM ET at 1–877 GO KOMEN (465–6636) or email firstname.lastname@example.org.